Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Core Viewpoint - Akoya Biosciences (AKYA) is expected to report a year-over-year increase in earnings driven by higher revenues, with the earnings report set for May 13, 2024, being crucial for stock price movement [1] Financial Expectations - The consensus estimate anticipates a quarterly loss of $0.30 per share, reflecting a year-over-year change of +38.8% [2] - Revenues are projected to be $24.13 million, which is a 12.7% increase from the same quarter last year [2] Estimate Revisions - The consensus EPS estimate has been revised 0.66% lower in the last 30 days, indicating a reassessment by analysts [2] - Akoya's Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -7.56%, suggesting a bearish outlook from analysts [5] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, with a focus on the Most Accurate Estimate [3] - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [4] Historical Performance - In the last reported quarter, Akoya was expected to post a loss of $0.27 per share but actually reported a loss of $0.22, resulting in a surprise of +18.52% [7] - Over the last four quarters, Akoya has beaten consensus EPS estimates two times [7] Industry Context - In the Zacks Medical - Biomedical and Genetics industry, IGM Biosciences, Inc. (IGMS) is expected to report a loss of $0.84 per share, with a year-over-year change of +36.8% and revenues of $0.71 million, up 36.5% from the previous year [9] - IGM Biosciences has an Earnings ESP of 1.69% and a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [9]